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Background: There is limited information on the impact on perioperative fluid intervention on complications and
length of hospital stay following pancreaticoduodenectomy. Therefore, we conducted a detailed analysis of fluid
intervention in patients undergoing pancreaticoduodenectomy at a university teaching hospital to test the
hypothesis that a restrictive intravenous fluid regime and/or a neutral or negative cumulative fluid balance, would
impact on perioperative complications and length of hospital stay.
Methods: We retrospectively obtained demographic, operative details, detailed fluid prescription, complications
and outcomes data for 150 consecutive patients undergoing pancreaticoduodenectomy in a university teaching
hospital. Prognostic predictors for length of hospital stay and complications were determined.
Results: One hundred and fifty consecutive patients undergoing pancreaticoduodenectomy were evaluated
between 2006 and 2012. The majority of patients were, middle-aged, overweight and ASA class III. Postoperative
complications were frequent and occurred in 86 patients (57%). The majority of complications were graded as
Clavien-Dindo Class 2 and 3. Postoperative pancreatic fistula occurred in 13 patients (9%), and delayed gastric
emptying occurred in 25 patients (17%). Other postoperative surgical complications included sepsis (22%), bile leak
(4%), and postoperative bleeding (2%). Serious medical complications included pulmonary edema (6%), myocardial
infarction (8%), cardiac arrhythmias (13%), respiratory failure (8%), and renal failure (7%). Patients with complications
received a higher median volume of intravenous therapy and had higher cumulative positive fluid balances.
Postoperative length of stay was significantly longer in patients with complications (median 25 days vs. 10 days;
p < 0.001). After adjustment for covariates, a fluid balance of less than 1 litre on postoperative day 1 and surgeon
caseloads were associated with the development of complications.
Conclusions: In the context of pancreaticoduodenectomy, restrictive perioperative fluid intervention and negative
cumulative fluid balance were associated with fewer complications and shorter length of hospital stay. These
findings provide good opportunities to evaluate strategies aimed at improving perioperative care.Background
It is recognized that liberal fluid administration is com-
mon practice after major hepatobiliary and pancreatic
surgery [1]. However, there is limited information on
perioperative fluid therapy and its impact on complica-
tions and length of hospital stay following pancreatico-
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reproduction in any medium, provided the orprograms may reduce the length of hospital stay follow-
ing PD [2,3], the independent role of intravenous fluid
therapy remains unclear due to the complex nature of
such programs and the lack of randomized controlled
trials. Therefore, we conducted a retrospective detailed
analysis of detailed fluid intervention in patients under-
going PD at a university teaching hospital to determine
the impact of fluid therapy on complications and length
of hospital stay. We tested the hypothesis that a restrict-
ive intravenous fluid regime and/or a neutral or negative
cumulative fluid balance would be associated with fewerral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Summary of number of patients undergoing
pancreaticoduodenectomy with complications
Total patients undergoing pancreaticoduodenectomy 150
Patients with complications 86(57%)





















Urinary tract infectionn 4(3%)
Postoperative deleriumo 6(4%)
Patient outcomes
Return to theatre 11(7%)
Unexpected return to intensive care unit 8(5%)
Medical emergency/response call 15(10%)
Death within 30 days 3(2%)
Data presented as number (%).
aInternational Study Group of Pancreatic Fistula (ISGPF).
bPresence of bile in the drainage fluid that persisted on postoperative day 4.
cElevations in serum lipase > 3× normal laboratory reference range.
dInternational Study Group of Pancreatic Fistula (ISGPF).
ePostoperative blood loss requiring a blood transfusion.
fSurviving sepsis campaign: international guidelines definition.
gRadiological features of acute pulmonary edema requiring medical intervention.
hECG changes with myocardial enzyme elevation.
iNew onset atrial fibrillation or ventricular arrhythmia requiring medical
treatment or cardioversion.
jProlonged ventilation or reintubation or PaO2 ≤ 50 mmHg or PaCO2 ≥
50 mmHg (room air).
kShortness of breath with crepitations and desaturation requiring medical
intervention.
lElevated temperature with radiographic pulmonary changes.
mRise in serum creatinine (absolute increase in serum creatinine of ≥ 0.3 mg/dl
(≥ 26.4 μmol/l) or percentage increase in serum creatinine of ≥ 50%) or oliguria
(urine output < 0.5 ml/kg/h for more than 6 hours).
nPositive urine culture for pathogens requiring antibiotics.
oImpaired cognition, fluctuating level of consciousness with altered psychomotor
activity not related to emergence from anesthesia or an identifiable etiology.
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pital stay.
Methods
After Austin Health Human Research Ethics Committee
approval, we conducted a retrospective analysis of
consecutive patients undergoing open PD at a univer-
sity teaching hospital with expertise in hepatobiliary-
pancreatic surgery including liver transplantation. A total
of 150 consecutive patients between January 2006 and
November 2012 were included. Patients undergoing total,
distal or completion pancreatectomy were excluded from
analysis. Data was extracted from a prospectively managed
electronic hospital database. Comprehensive cross checks
using computerized medical records were reviewed by
three independent investigators who checked that a thor-
ough and accurate tally of fluid administration, losses and
complications were recorded. All biochemical, hematolo-
giocal, laboratory and radiological results were reviewed.
Any complication coded by the hospital in the health in-
formation database was cross checked with clinical re-
cords to ensure that the complication was correctly
reported and coded. Complications were recorded as un-
expected events occurring during surgery or the postoper-
ative period, with pancreatic leak and delayed gastric
emptying graded and classified according to the Inter-
national Study Group of Pancreatic Surgery [4-6]. Com-
plications were graded according to Clavien-Dindo
Classification [7]. Common Terminology Criteria for Ad-
verse Events were classified according to the US Depart-
ment of Health and Human Services, National Institute of
Health and National Cancer Institute [8] and detailed in
Table 1. Characteristics of the cohort recorded included
patient demographics, body mass index, American Society
of Anesthesiologists (ASA) class, comorbidities and pre-
operative laboratory tests. Operative details collected in-
cluded pathology, anesthetic technique, the volume of
cases performed by each surgeon, and intraoperative fluid
administration. Specifics of intravenous fluid administra-
tion from the first to third postoperative days were col-
lected including fluid type (crystalloid, colloid, blood) and
daily fluid balances. Finally, data regarding clinical compli-
cations were compiled in conjunction with length of hos-
pital stay.
We defined a restrictive fluid regime as: intraoperative
fluid therapy ≤ 4 litres, day 1 fluids ≤ 3 litres, day 2
fluids ≤ 2 litres, and day 3 fluids ≤ 1.5 litres or a neutral
or negative cumulative fluid balance at the same time
points. A liberal fluid regime was defined as intraopera-
tive fluid therapy > 5 litres, day 1 fluids > 4 litres, day 2
fluids > 3 litres, and day 3 fluids > 2 litres or a positive
cumulative fluid balance at the same time points. This def-
inition was selected to be consistent with the “REstrictive
Versus LIbEral Fluid Therapy in Major Abdominal
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package (SPSS Version 19.0; IBM Co, Armonk, NY, USA)
was used for statistical analysis, with a two-tailed P value
less than 0.05 as statistically significant. Results were
expressed as either a median (range) or in the form of fre-
quencies unless otherwise stated. Comparisons between
categorical variables were determined by chi-square and
Fisher’s exact test as appropriate. Non-categorical vari-
ables were assessed by the Mann–Whitney U test. Multi-
variate analysis was undertaken using a backward stepwise
logistic regression model to identify factors associated
with postoperative discharge by day 14, including all fac-
tors where the P value was less than 0.1 on univariate ana-
lysis. A cut off of 14 days represented the median length
of stay for patients undergoing uncomplicated PD at our
institution [1]. Odds ratios (OR) and 95% confidence in-
tervals (CI) were reported where appropriate.
Results
One hundred and fifty consecutive patients undergoing
PD were evaluated between 2006 and 2012. The majority
of patients were male (59%), middle-aged (mean: 66 years
old), overweight (mean: BMI 26.1 kg/m2) and ASA class
III (76%) (Table 2). Details of postoperative complica-
tions are summarised in Table 1. Postoperative compli-
cations were frequent and occurred in 86 patients (57%).
The majority of complications were graded as Clavien-













Hemoglobin (g/l) 130 (79–173)
WCC (×109/l) 7.5 (3.0–31.6)
Platelets (×109/l) 292 (21–744)
Bilirubin (μmol/l) 29 (5–405)
Albumin (g/l) 34 (13–49)
Urea (mmol/l) 5.3 (0.9–15.4)
Creatinine (μmol/l) 76 (10–241)
ASA – American society of anesthesiologists; BMI – body mass index; WCC – white cell
Hemoglobin 5 WCC 9 Platelets 7 Bilirubin 32, Albumin 35, Urea 10, Creatinine 10 *p≤ 0fistula occurred in 13 patients (9%), and delayed gastric
emptying occurred in 25 patients (17%). Other docu-
mented postoperative surgical complications included
sepsis (22%), bile leak (4%), postoperative bleeding (2%)
and acute pancreatitis (5%). Serious medical complica-
tions included pulmonary edema (6%), myocardial in-
farction (8%), respiratory failure (8%), and renal failure
(7%). Broadly, the characteristics of patients with com-
plications were similar to patients without complications
(Table 3).
The operative details and pathologies of patients
undergoing PD with and without complications are
summarised in Table 4. Surgeons who performed fewer
pancreaticoduodenectomies appeared to have higher
complication rates than surgeons with higher surgical
caseloads (p < 0.001). Patients without complications had
a higher median estimated blood loss (400 ml; range
200–2500 ml vs. 350 mL; range 100–1900 ml, p = 0.027),
however blood transfusion requirements were similar in
both groups (19%). Intraoperatively patients with com-
plications were more likely to receive a liberal fluid
intervention regime (median 5.4 litres; range 2.5-12.3 li-
tres vs. 5.0 litres; range 1.0-10.6 litres; p = 0.047), and
were in a more positive fluid balance (median 4.7 litres;
range 1.6-12.0 litres vs. 4.1 litres; range 0.2-9.4 litres; p =
0.044) compared to patients without complications.
Complication rates were similar in patients who received
intrathecal morphine or epidural anesthesia compared toodenal resection with and without complications
Complications No complications
p value
(n = 86) (n = 64)
53 (62%) 36 (56%) 0.507
67 (41–84) 66 (15–82) 0.496
26 (18–37) 24 (19–42) 0.046*
1 (1%) 0 (0%) 1.0
20 (23%) 15 (23%)
65 (76%) 49 (77%)
24 (28%) 11 (17%) 0.125
9 (11%) 3 (5%) 0.237
130 (82–173) 129 (79–156) 0.410
7.6 (4.1–31.6) 7.0 (3.0–16.8) 0.160
293 (21–733) 290 (139–744) 0.605
35 (5–405) 19 (6–352) 0.109
34 (20–46) 35 (13–49) 0.045*
5.3 (0.9–12.2) 5.2 (1.1–15.4) 0.987
79 (10–241) 70 (28–186) 0.036*
count, COPD – Chronic obstructive pulmonary disease; Missing values; BMI −24
.05 Chi-Square/Fisher’s exact test/Mann–Whitney U test.
Table 3 Characteristics of patients undergoing pancreaticoduodenal resection with and without complications
Overall Complications No complications p value
(n = 150) (n = 86) (n = 64)
Patient characteristics
Male 89 (59%) 53 (62%) 36 (56%) 0.507
Age 67 (15–84) 67 (41–84) 66 (15–82) 0.496
BMI 26 (18–42) 26 (18–37) 24 (19–42) 0.046*
ASA Class I 1 (1%) 1 (1%) 0 (0%) 1.0
II 35 (23%) 20 (23%) 15 (23%)
III 114 (76%) 65 (76%) 49 (77%)
Diabetes 35 (23%) 24 (28%) 11 (17%) 0.125
COPD 12 (8%) 9 (11%) 3 (5%) 0.237
Preoperative laboratory tests
Hemoglobin (g/l) 130 (79–173) 130 (82–173) 129 (79–156) 0.410
WCC (×109/l) 7.5 (3.0–31.6) 7.6 (4.1–31.6) 7.0 (3.0–16.8) 0.160
Platelets (×109/l) 292 (21–744) 293 (21–733) 290 (139–744) 0.605
Bilirubin (μmol/l) 29 (5–405) 35 (5–405) 19 (6–352) 0.109
Albumin (g/l) 34 (13–49) 34 (20–46) 35 (13–49) 0.045*
Urea (mmol/l) 5.3 (0.9–15.4) 5.3 (0.9–12.2) 5.2 (1.1–15.4) 0.987
Creatinine (μmol/l) 76 (10–241) 79 (10–241) 70 (28–186) 0.036*
ASA – American Society of Anesthesiologists; BMI – body mass index; WCC – white cell count, COPD – Chronic obstructive pulmonary disease; Missing values; BMI −24
Haemoglobin 5 WCC 9 Platelets 7 Bilirubin 32, Albumin 35, Urea 10, Creatinine 10 *p ≤ 0.05 Chi-Square/Fisher’s exact test/Mann–Whitney U test.
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intraoperative inotropes or vasoconstrictors for patients
with or without complications (Table 4).
Table 5 summarizes the detailed administration of
postoperative intravenous fluids in the first three postop-
erative days in patients with and without complications.
The majority of fluids given were in the form of crystal-
loids. The overall median volumes of intravenous fluids
given on the first three postoperative days were 3.0 litres
on day 1 (range 0.9-14.1 litres), 2.1 litres on day 2 (range
0.3-6.1 litres), and 1.7 litres on day 3 (range 0–6.0 litres).
On all three postoperative days, patients with complica-
tions received a higher median volume of intravenous
therapy (day 1: 3.3 litres vs. 2.9 litres, p = 0.020; day 2:
2.3 litres vs.1.9 litres, p = 0.026; day 3: 1.9 litres vs.1.4 li-
tres, p = 0.018) and had higher cumulative positive fluid
balances when compared to patients without complica-
tions (Table 5). Of interest, within the complication
group itself, the fluid balance in patients with Clavien-
Dindo grade 1 and 2 complications were not
significantly different to those with grade 3, 4 or 5 com-
plications. Postoperative length of stay was significantly
greater in patients with complications when compared to
patients without complications (median 25 days vs.
10 days; p < 0.001). Factors associated with complications
were creatinine >100 μmmol/L, liberal fluid intervention,
positive cumulative fluid balance, and a low individual sur-
gical caseloads (Table 6). After adjustment for covariates,a fluid balance of less than 1 litre on postoperative day 1,
and low surgeon caseloads remained strongly associated
with the development of complications. Similarly, a fluid
balance of less than 1 litre on postoperative day 1 (OR 2.9;
95% CI: 1.1-6.6, p = 0.037), absence of complications (OR
0.1; 95% CI 0.0-0.2; p < 0.001) and high surgeon caseloads
(OR 9.8; 95% CI 3.3-33.8; p < 0.001) remained strongly as-
sociated with an earlier hospital discharge (Table 7). There
were no significant differences in any of the outcomes re-
ported when factoring in time effects over the 7-year study
period.
Discussion
We performed a retrospective study of detailed fluid
intervention, complications and length of hospital stay
in patients undergoing PD. We found that, as hypothe-
sized, restrictive fluid intervention and a neutral/negative
cumulative fluid balance were associated with reduced
complications and shorter length of hospital stay. Im-
portantly, we found that improvement in PD outcomes
occurred with increased surgical caseload, and surgeon
experience remained an important determinant of over-
all morbidity.
The demographic and clinical features of our patients
are consistent with other studies of similar types of sur-
gery [1,10-13]. Likewise our complication rates appear to
be similar to other university hospital hepatobiliary units
[14,15]. However, as there are no studies assessing the
Table 4 Operative and pathology of patients undergoing pancreaticoduodenal resection with and without complications
Overall Complications No complications p value
(n = 150) (n = 86) (n = 64)
Malignancy 125 (83%) 74 (86%) 51 (80%) 0.301
Epidural anesthesia 84 (57%) 45 (53%) 39 (62%) 0.276
Intrathecal morphine 20 (13%) 8 (9%) 12 (19%) 0.092
Pylorus preserving 63 (42%) 40 (47%) 23 (36%) 0.194
Surgeons with higher surgical volumes* 0.001*
Surgeon 1 52 (35%) 17 (20%) 35 (55%)
Surgeon 2 29 (19%) 19 (22%) 10 (16%)
Surgeon 3 13 (9%) 8 (9%) 5 (8%)
Surgeon 4 9 (6%) 6 (7%) 3 (5%)
Surgeon 5 20 (13%) 15 (17%) 5 (8%)
Other 27 (18%) 21 (24%) 6 (9%)
Estimated blood loss (ml) 350 (100–2500) 350 (100–1900) 400 (200–2500) 0.027*
Blood transfusions intraoperative 28 (19%) 16 (19%) 12 (19%) 0.982
Intraoperative fluids (l) 5.0 (1.0–12.3) 5.4 (2.5–12.3) 5.0 (1.0–10.6) 0.047*
Fluid balance (l) 4.5 (0.2–12.0) 4.7 (1.6–12.0) 4.1 (0.2–9.4) 0.044*
Inotropes and vasoconstrictors
0.89
Total use 90 (60%) 55 (64%) 35 (55%)
Norepinephrine 8 (5%) 5 (6%) 3 (5%)
Metaraminol 70 (47%) 39 (45%) 31 (48%)
Ephedrine 15 (10%) 9 (10%) 8 (13%)
Dopamine 5 (3%) 3 (3%) 2 (3%)
Operative time (hours) 7.0 (3–15.8) 6.6 (3–15.8) 7.2 (3–12) 0.056
*Defined as greater than 10 pancreatic resections per annum.
Weinberg et al. BMC Anesthesiology 2014, 14:35 Page 5 of 8
http://www.biomedcentral.com/1471-2253/14/35effects of perioperative cumulative fluid balances on ad-
verse outcomes and length of hospital stay following PD,
direct comparisons are not possible. However, a recent
study by Melis et al. examined the influence of intraop-
erative crystalloid administration on complications fol-
lowing PD for pancreatic adenocarcinoma [11]. The
volume of intraoperative crystalloid administered in-
creased with duration of surgery, intraoperative blood
loss and intra-operative blood transfusion, but unlike
our data, this did not correlate with postoperative mor-
bidity. However, perioperative fluid balances were not
reported. Perioperative cumulative fluid balance has
been shown to be an important predictor of surgical out-
comes and can be used as a prognostic tool to evaluate
the risk of surgical complications [12]. Our study sup-
ports these findings that a positive cumulative fluid bal-
ance is associated with more complications and a longer
length of hospital stay. We found the difference in lib-
eral intravenous fluid intervention to be most apparent
in the postoperative setting. Even after adjustment for
covariates, a positive fluid balance on postoperative day
1 remained strongly associated with of the length of hos-
pital stay. Patients with postoperative complications hada longer length of hospital stay compared to patients
without complications (median 25 days vs. 10 days; p =
0.001). This finding is similar to data from other multi-
centre Australian studies [13]. Importantly, complication
rates of PD and the associated length of hospital stay
continue to affect patient outcomes and strain limited
healthcare resources [14].
Similar to other studies we found the surgical case
load to have a significant impact on perioperative mor-
bidity following PD [16-19]. Pancreaticoduodenectomy
has an inherent learning curve and it has been suggested
that after sixty cases, surgeons performing PD achieve
significantly decreased blood loss, operative time, and
length of hospital stay, and carry out more margin-
negative resections [16-19].
There are several limitations of our study. Although
this is the largest study examining the association of de-
tailed fluid intervention, fluid balance and surgical out-
comes in patients undergoing PD, only 150 patient
records were reviewed. Data was collected from a hos-
pital maintained database, which limited our ability to
recover any missing or unclear data. Similar to a previ-
ous study [1], it is possible that not all complications
Table 5 Postoperative and outcome details of patients undergoing pancreaticoduodenal resection with and without
complications
Overall Complications No complications
p value
(n = 150) (n = 86) (n = 64)
Day 1 total fluids (litres) 3.0 (0.9–14.1) 3.3 (0.9–14.1) 2.9 (1.4-11.0) 0.020*
- Crystalloid 2.7 (0.9–13.1) 2.8 (0.9–13.1) 2.6 (1.3–10.0) 0.101
– Colloid 0.0 (0.0–2.8) 0.0 (0.0–2.8) 0.0 (0.0–2.0) 0.952
– Blood 0.0 (0.0–1.1) 0.0 (0.0–1.1) 0.0 (0.0–0.3) 0.239
– Fluid balance 1.5 (−1.7–12.1) 1.8 (−1.7 – 12.1 0.9 (−0.8–8.4) 0.002*
Day 2 total fluids (litres) 2.1 (0.3–6.1) 2.3 (0.3–6.1) 1.9 (0.7–4.9) 0.026*
– Crystalloid 2.0 (0.3–5.5) 2.2 (0.4–5.5) 1.90.7–4.4) 0.009*
– Colloid 0.0 (0.0–1.9) 0.0 (0.0–1.9) 0.0 (0.0–0.7) 0.146
– Blood 0.0 (0.0–0.6) 0.0 (0.0–0.6) 0.0 (0.0–0.5) 0.866
– Fluid balance 0.4 (−2.9–4.5) 0.6 (−2.9–4.5) 0.2 (−2.4–5.3) 0.037*
Day 3 total fluids (litres) 1.7 (0.0–6.0) 1.9 (0.1–6.0) 1.4 (0.0–4.0) 0.018*
– Crystalloid 1.6 (0.0–6.0) 1.9 (0.1–6.0) 1.4 (0–4.0) 0.028*
– Colloid 0.0 (0.0–1.3) 0.0 (0.0–1.1) 0.0 (0.0–1.3) 0.220
– Blood 0.0 (0.0–0.8) 0.0 (0.0–0.8) 0.0 (0.0.4) 0.727
– Fluid balance 0.4 (−2.9–11.9) 0.5 (−2.6–11.9) 0.2 (−2.9–11.7) 0.103
Postoperative length of stay (days) 17 (6–140) 25 (7–140) 10 (6–90) <0.001
*p ≤ 0.05 Mann Whitney U test.
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ticular appears to identify only patients with Grade B, C
leaks, with the possibility that Grade A leaks have been
under-reported. However, this would simply reinforce
the contention that these patients experience a high level
of postoperative complications. There may also have
been inaccuracies in the recording of fluid therapy. WeTable 6 Factors associated with overall complications followin
Complications No complications
(n = 86) (n = 64)
Demographics
BMI≥ 25 43 (62%) 28 (49%)
Albumin≤ 30 g/l 19 (34%) 9 (15%)
Creatinine >100 (μmol/l) 17 (22%) 6 (10%)
Operative details
Time≥ 8 hours 24 (28%) 25 (39%)
Blood loss≥ 600 ml 15 (18%) 14 (22%)
Intraoperative fluid balance ≤ 3 litre 29 (34%) 32 (50%)
High surgical volume 12 (14%) 21 (33%)
Post–operative details
Day 1 fluid balance ≤ 1 litre 26 (30%) 36 (56%)
Day 2 fluid balance ≤ 0.2 litre 28 (33%) 32 (50%)
Day 3 fluid balance ≤ 0.2 litre 36 (42%) 32 (50%)
Data are presented as number (%) or median (range).
BMI – body mass index; Missing: BMI – 24, Albumin −35, Creatinine 10, Estimate bloconsider this unlikely due to our comprehensive intraop-
erative fluid therapy documentation practices, cross
checks, and computerized medical records. In addition,
the medical records were reviewed by three independent
investigators who checked that a thorough and accurate
tally of fluid administration and losses was recorded.
This is a single centre study, which may limit theg pancreaticoduodenectomy
Univariate Multivariate
Odds ratio
(Confidence interval) p value
Odds ratio
(Confidence interval) p value
1.7 (0.8–3.5) 0.137
2.9 (1.2–7.40 0.020* 1.6 (0.6–4.6) 0.389
2.6 (1.0–7.1) 0.055 3.9 (1.1–13.4) 0.033*
0.6 (0.3–1.2) 0.150
0.8 (0.4–1.7) 0.510
0.3 (0.1–0.7) 0.006* 0.6 (0.2–1.7) 0.367
0.2 (0.1–0.4) <0.001* 0.2 (0.1–0.5) 0.001*
0.4 (0.2–0.7) 0.001* 0.2 (0.1–0.6) 0.001*
0.5 (0.3–0.9) 0.031* 0.8 (0.3–2.1) 0.685
0.7 (0.4–1.4) 0.32
od loss - 3 *p ≤ 0.05; Chi-Square/Fisher’s exact test.








p value Odds ratio
(Confidence interval) p value
(n = 62) (n = 88)
Demographics
Male 41 (66%) 48 (55%) 1.6 (0.8–3.2) 0.155
Diabetes 16 (26%) 19 (22%) 1.3 (0.6–2.7) 0.548
COPD 2 (3%) 10 (11%) 0.3 (0.1–1.2) 0.124
Age≥ 70 20 (32%) 38 (43%) 0.6 (0.3–1.2) 0.176
BMI≥ 25 29 (50%) 42 (62%) 0.6 (0.3–1.3) 0.184
Albumin≤ 30 g/l 12 (21%) 16 (28%) 0.7 (0.3–1.7) 0.414
Creatinine ≥100 (μmol/l) 6 (10%) 17 (21%) 0.4 (0.2–1.2) 0.088 0.3 (0.1–1.2) 0.085
Operative details
Time≥ 8 hours 24 (39%) 25 (28%) 1.6 (0.8–3.1) 0.185
Blood loss≥ 600 ml 9 (15%) 20 (23%) 0.6 (0.2–1.4) 0.202
Intraoperative fluid balance ≤ 3 litre 20 (32%) 13 (15%) 2.7 (1.2–6.1) 0.01* 1.7 (0.5–5.1) 0.382
High surgical volume 39 (63%) 13 (25%) 9.8 (4.5–21.4) <0.001* 11.3 (3.8–33.8.) <0.001*
Malignancy 49 (79%) 76 (86%) 0.6 (0.3–1.4) 0.235
Post–operative details
Complication 15 (24%) 71 (80%) 0.1 (0.0–0.2) <0.001* 0.1 (0.1–0.4) <0.001*
Day 1 fluid balance ≤ 1 litre 35 (57%) 27 (31%) 2.9 (1.5–5.8) 0.002* 2.9 (1.1–6.6) 0.037*
Day 2 fluid balance ≤ 0.2 litre 33 (53%) 37 (31%) 2.6 (1.3–5.0) 0.006* 0.8 (0.3–2.5) 0.752
Day 3 fluid balance ≤ 0.2 litre 36 (58%) 32 (36%) 2.4 (1.2–4.7) 0.009* 2.5 (1.0–6.6) 0.056
Data are presented as number (%) or median (range).
COPD – Chronic obstructive pulmonary disease. BMI – body mass index; Missing: BMI – 24, Albumin −35, Creatinine 10, Estimate blood loss - 3 *p ≤ 0.05; Chi-Square/
Fisher’s exact test.
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has all the typical characteristics of a tertiary institution
in a developed country and a recent comparative study
confirmed that its patients and their outcomes were
equivalent to those of other tertiary hospitals in
Australia [20]. Our study has several strengths. Informa-
tion on detailed perioperative fluid intervention and
fluid balances provide a background for power calcula-
tions needed to design future prospective fluid interven-
tional trials in this group of patients. Finally, by defining
the complication and mortality rate in these patients, we
have identified a need for improved perioperative care,
and a possible pathway to achieve this goal.
Whilst the findings of this study suggest that positive
fluid balance is associated with postoperative complica-
tions and increased length of hospital stay in the setting
of PD, this does not imply causality. Increased periopera-
tive fluid intervention may occur as a consequence of
complications. Sepsis, peritonitis, renal and cardiac fail-
ure, and pancreatic leak all can cause fluid retention
and/or edema. Fluid balance may therefore simply be a
marker of illness rather than the cause. It is also plaus-
ible that both of these mechanisms co-exist. Whilst thereis emerging evidence that early goal directed therapy
and fast track programs improve surgical outcomes and
reduce postoperative hospital stay [21,22], there is lim-
ited information on detailed fluid intervention and cu-
mulative fluid balance in the context of PD.
Conclusions
Therefore, these results demonstrate that a high surgical
caseload and a restrictive perioperative fluid intervention
regime, with negative cumulative fluid balance were as-
sociated with fewer complications and shorter length of
hospital stay. These findings, specific to patients under-
going PD, are of particular interest as the higher rates of
complications and prolonged length of stay provide good
opportunities to evaluate strategies aimed at improving
perioperative care for this group.
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